Valerie Lapierre
Overview
Explore the profile of Valerie Lapierre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
953
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia
Deschamps P, Wacheux M, Gosseye A, Morabito M, Pages A, Lyne A, et al.
J Clin Invest
. 2024 Nov;
134(22).
PMID: 39545419
Chronic myelomonocytic leukemia (CMML) is a severe myeloid malignancy with limited therapeutic options. Single-cell analysis of clonal architecture demonstrates early clonal dominance with few residual WT hematopoietic stem cells. Circulating...
2.
Faugeroux V, Pailler E, Oulhen M, Deas O, Brulle-Soumare L, Hervieu C, et al.
Nat Commun
. 2020 Apr;
11(1):1884.
PMID: 32313004
Transformation of castration-resistant prostate cancer (CRPC) into an aggressive neuroendocrine disease (CRPC-NE) represents a major clinical challenge and experimental models are lacking. A CTC-derived eXplant (CDX) and a CDX-derived cell...
3.
Kerbage F, Sakr R, Lapierre V, Alexandrova K, Coman T, Leroux S, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Feb;
20(4):209-211.
PMID: 32019730
Allogeneic hematopoietic cell transplantation (AHCT) represents the only curative therapy for many hematological malignancies. The graft versus leukemia effect, driven by donor T cells, plays a major role in its...
4.
Andree K, Mentink A, Zeune L, Terstappen L, Stoecklein N, Neves R, et al.
Int J Cancer
. 2018 Jul;
143(10):2584-2591.
PMID: 30006930
Frequently, the number of circulating tumor cells (CTC) isolated in 7.5 mL of blood is too small to reliably determine tumor heterogeneity and to be representative as a "liquid biopsy"....
5.
Adler M, Lapierre V, Sakr R, Bourhis J, Gachot B, Castilla-Llorente C, et al.
J Infect Dis
. 2018 Mar;
217(11):1844-1845.
PMID: 29547928
No abstract available.
6.
Anderson M, Chaze T, Coic Y, Injarabian L, Jonsson F, Lombion N, et al.
Cell Chem Biol
. 2018 Feb;
25(4):483-493.e9.
PMID: 29478905
Neutrophils represent the most abundant immune cells recruited to inflamed tissues. A lack of dedicated tools has hampered their detection and study. We show that a synthesized peptide, MUB, binds...
7.
Zhang Y, He L, Selimoglu-Buet D, Jego C, Morabito M, Willekens C, et al.
Blood Adv
. 2018 Jan;
1(14):972-979.
PMID: 29296739
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder that typically associates with mutations in epigenetic, splicing, and signaling genes. Genetically modified mouse models only partially recapitulate the...
8.
Messaoudi K, Ali A, Ishaq R, Palazzo A, Sliwa D, Bluteau O, et al.
Nat Commun
. 2017 Nov;
8(1):1786.
PMID: 29176689
Thrombocytopenia is a major side effect of a new class of anticancer agents that target histone deacetylase (HDAC). Their mechanism is poorly understood. Here, we show that HDAC6 inhibition and...
9.
Saleh K, Danu A, Koscielny S, Legoupil C, Pilorge S, Castilla-Llorente C, et al.
Leuk Lymphoma
. 2017 Nov;
59(11):2580-2587.
PMID: 29164977
The combination of carmustine, etoposide, aracytin, and melphalan(BEAM) conditioning regimen in autologous stem-cell transplantation (ASCT) is widely used in patients with relapsed/refractory non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma. It is...
10.
Roy A, Lordier L, Mazzi S, Chang Y, Lapierre V, Larghero J, et al.
Blood
. 2016 Oct;
128(26):3137-3145.
PMID: 27737892
Megakaryocyte polyploidy is characterized by cytokinesis failure resulting from defects in contractile forces at the cleavage furrow. Although immature megakaryocytes express 2 nonmuscle myosin II isoforms (MYH9 [NMIIA] and MYH10...